Astellas Pharma Inc., and Mitsui Fudosan Co., Ltd., will establish a TME imaging and interactive research for innovation (TMEiLab) that is scheduled to open in Oct. 2023. The two companies will collaborate to maximize the benefits of the Kashiwa-no-ha area, which is located close to leading Japanese cutting-edge medical facilities and academia, including National Cancer Center Japan, with the aim of gaining new insights about the tumor microenvironment, a challenge in refractory cancer, and g...